PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (E)-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-buten-2-one | 201-224-3 | 79-77-6 | - | - | 2 | - | 1 | - | - | - | - | Details |
| 2,5-di-tert-pentylhydroquinone | 201-222-2 | 79-74-3 | 1 | 1 | 2 | - | - | - | - | - | - | Details |
| 4-(2,5,6,6-tetramethyl-1-cyclohexen-1-yl)-3-buten-2-one | 201-220-1 | 79-70-9 | - | - | - | - | 1 | - | - | - | - | Details |
| 4-(2,5,6,6-tetramethylcyclohex-2-enyl)but-3-en-2-one | 201-219-6 | 79-69-6 | - | - | - | - | 1 | - | - | - | - | Details |
| 2-nitropropane | 201-209-1 | 79-46-9 | - | - | - | - | 1 | - | - | - | - | Details |
| Dichloroacetic acid | 201-207-0 | 79-43-6 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Methacrylic acid | 201-204-4 | 79-41-4 | - | - | 1 | - | 1 | - | - | - | - | Details |
| methacrylamide | 201-202-3 | 79-39-0 | 1 | - | 3 | - | - | - | - | - | - | Details |
| Chlorotrifluoroethylene | 201-201-8 | 79-38-9 | - | - | 1 | - | - | - | - | - | - | Details |
| Dichloroacetyl chloride | 201-199-9 | 79-36-7 | - | - | - | - | 1 | - | - | - | - | Details |
| L-(+)-lactic acid | 201-196-2 | 79-33-4 | - | - | 3 | - | - | 1 | - | - | - | Details |
| Isobutyric acid | 201-195-7 | 79-31-2 | - | - | 2 | - | 1 | - | - | - | - | Details |
| Nitroethane | 201-188-9 | 79-24-3 | - | - | 3 | - | 1 | 1 | - | - | - | Details |
| Peracetic acid | 201-186-8 | 79-21-0 | - | - | 3 | 1 | - | 1 | - | - | - | Details |
| N-methylacetamide | 201-182-6 | 79-16-3 | - | - | 1 | - | 1 | - | 1 | - | - | Details |
| Glycollic acid | 201-180-5 | 79-14-1 | - | - | 1 | - | - | - | - | - | - | Details |
| Chloroacetic acid | 201-178-4 | 79-11-8 | - | - | 3 | - | 1 | - | - | - | - | Details |
| Acrylic acid | 201-177-9 | 79-10-7 | - | - | 3 | - | 1 | - | - | - | - | Details |
| Propionic acid | 201-176-3 | 79-09-4 | - | - | 1 | - | - | - | - | - | - | Details |
| 2-chloroacetamide | 201-174-2 | 79-07-2 | - | - | 1 | - | - | - | - | - | - | Details |
| Acrylamide | 201-173-7 | 79-06-1 | - | - | - | - | - | - | 1 | - | - | Details |
| Propionamide | 201-172-1 | 79-05-0 | - | - | - | - | 1 | - | - | - | - | Details |
| Chloroacetyl chloride | 201-171-6 | 79-04-9 | - | - | - | - | 1 | - | - | - | - | Details |
| Trichloroethylene | 201-167-4 | 79-01-6 | - | - | 1 | - | - | - | 1 | 1 | - | Details |
| 5-[[4-chloro-6-[(3-sulphophenyl)amino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[[4-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]naphthalene-2,7-disulphonic acid, sodium salt | 279-015-1 | 78952-61-1 | - | - | 2 | - | 1 | - | - | - | - | Details |